Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2025-12-25 @ 7:39 PM
Study NCT ID:
NCT06012435
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-15
First Post:
2023-08-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Sponsor:
Seagen, a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-21
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-03-11
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-21
First Submit QC Date:
None
Study First Post Date:
2023-08-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-08
Last Update Post Date:
2025-12-15
Last Update Post Date Type:
ESTIMATED